Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Cancer Res Clin Oncol ; 132(4): 205-12, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16402269

ABSTRACT

PURPOSE: This randomized phase III study compared bendamustine and prednisone (BP) to standard melphalan and prednisone (MP) treatment in previously untreated patients with multiple Myeloma (MM). PATIENTS AND METHODS: To be included, patients had to have histologically and cytologically proven stage II with progressive diseases or stage III MM. They were randomly assigned to receive BP (n=68) or MP (n=63). The primary endpoint was the time to treatment failure (TTF). Secondary endpoints included survival, remission rate, toxicity and quality of life. RESULTS: The overall response rate was 75% in the BP and 70% in the MP group. A significantly higher number of patients treated with BP achieved a complete remission than did patients receiving MP (32 vs. 13%; P=0.007), and the maximum response was achieved more rapidly in patients treated with BP compared to those receiving MP (6.8 vs. 8.7 cycles; P<0.02). TTF and remission duration were significantly longer in the BP group. Patients receiving BP had higher QoL scores and reported pain less frequently than patients receiving MP. CONCLUSION: BP is superior to MP with respect to complete remission rate, TTF, cycles needed to achieve maximum remission and quality of life and should be considered the new standard in first-line treatment of MM patients not eligible for transplantation.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Melphalan/administration & dosage , Multiple Myeloma/drug therapy , Nitrogen Mustard Compounds/administration & dosage , Prednisone/administration & dosage , Quality of Life , Adult , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Bendamustine Hydrochloride , Disease-Free Survival , Female , Germany, East , Humans , Male , Melphalan/adverse effects , Middle Aged , Multiple Myeloma/mortality , Multiple Myeloma/pathology , Nitrogen Mustard Compounds/adverse effects , Prednisone/adverse effects , Remission Induction , Survival Analysis , Time Factors , Treatment Failure
2.
Bone Marrow Transplant ; 27(11): 1125-32, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11551022

ABSTRACT

Mobilised peripheral blood stem cells are widely used for autografting in patients with chronic myeloid leukaemia (CML) and it is generally thought that a high proportion of Ph-negative progenitor cells in the graft is desirable. We report here the results of 91 stem cell mobilisations performed with various chemotherapy regimens followed by G-CSF. We show that mobilisation of Ph-negative cells is possible after diagnosis as well as in advanced stages of the disease. The yield of Ph-negative cells is highly dependent on the chemotherapy regimen: while the combination of idarubicin and cytarabin for 3-5 days (IC3-5) mobilised Ph-negative cells in most patients, high-dose cyclophosphamide was ineffective. Mobilisation of Ph-negative progenitor cells after IC3 was at least as effective as after IC5; however, less apheresis sessions were required, and toxicity was much reduced after IC3. Compared to historical controls, IC was equally effective as the widely used ICE/miniICE (idarubicin, cytarabin, etoposide) protocol. No correlation was found between graft quality and the cytogenetic response to subsequent treatment with interferon-alpha. We conclude that IC3 is an effective and well-tolerated regimen for mobilising Ph-negative cells that compares well with more aggressive approaches such as IC5 and ICE/miniICE.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Hematopoietic Stem Cell Mobilization/methods , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy , Adolescent , Adult , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Cyclophosphamide/administration & dosage , Cyclophosphamide/standards , Cyclophosphamide/toxicity , Cytarabine/administration & dosage , Cytarabine/standards , Cytarabine/toxicity , Female , Graft Survival/drug effects , Granulocyte Colony-Stimulating Factor/administration & dosage , Granulocyte Colony-Stimulating Factor/standards , Granulocyte Colony-Stimulating Factor/toxicity , Hematopoietic Stem Cell Mobilization/standards , Humans , Idarubicin/administration & dosage , Idarubicin/standards , Idarubicin/toxicity , Interferon-alpha/administration & dosage , Leukapheresis/standards , Male , Middle Aged , Philadelphia Chromosome
3.
Minerva Med ; 78(17): 1313-9, 1987 Sep 15.
Article in Italian | MEDLINE | ID: mdl-3313112

ABSTRACT

Patients with problems of internal medicine presenting at first-aid units of city hospitals represent a considerable work load. 1667 patients of this type have been examined retrospectively. The most numerous group had cardiocirculatory (22%) and nervous system (21%) problems, 9% had problems linked to their mental state and 11% dermatology complaints in general. 1047 patients underwent further investigation and/or specialist examination (247 neurological and 166 cardiological). Patients with jaundice, diabetes mellitus and cardiac decompensation underwent the highest number of laboratory examinations. The highest percentage of X-rays was done on patients suffering from chronic bronchitis during an acute episode, the highest percentage of ECGs in patients with prethoracic pain or cardiopalmus. In first aid also, some tests seem to be carried out as routine or for legal medicine purposes while for problems where tests are less easy or harder to understand (e.g. loss of consciousness episodes), a specialist is frequently brought in. The work load on the first-aid out-patients structure can be reduced by promoting greater awareness of the problem on the part of the internist and by rerouting users to non-hospital structures.


Subject(s)
Emergency Service, Hospital , Patient Discharge , Cardiovascular Diseases/diagnosis , Humans , Nervous System Diseases/diagnosis , Respiratory Tract Diseases/diagnosis , Retrospective Studies , Skin Diseases/diagnosis
4.
Z Gesamte Inn Med ; 30(15): 137-9, 1975 Aug 01.
Article in German | MEDLINE | ID: mdl-1189491

ABSTRACT

During a screening at a testing of 5 different protein parameters (IgG, IgA, IgM, Hp, Tf) different types of distribution were found. While IgG, Hp and Tf have a normal distribution, IgG and IgM are not normally distributed in the uncleansed group. Measures of elimination of suggested sizes of influence ("liver parameters") remained without effect.


Subject(s)
Blood Proteins/isolation & purification , Liver Diseases/diagnosis , Haptoglobins/isolation & purification , Humans , Immunoglobulin A/isolation & purification , Immunoglobulin G/isolation & purification , Immunoglobulin M/isolation & purification , Mass Screening , Transferrin/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...